 "KIMS Hospitals lists at 22 per cent premium over issue price")
Krishna Institute of Medical Sciences (KIMS) made a good debut at the bourses, on Monday, with the stock listing at Rs 1,009, up 22 per cent against its issue price of Rs 825 per share on the National Stock Exchange (NSE).
At 10:06 am, the stock was trading at Rs 1,003, after hitting a low of Rs 990 on the NSE and BSE. A combined 4.38 million shares have changed hands on the counter on both the exchanges, so far.
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It operates nine multi-specialty hospitals under the 'KIMS Hospitals' brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021.
The company has a flagship hospital at Secunderabad, which, according to Crisil, is one of the largest private hospitals in India at a single location with a capacity of 1,000 beds. At the end of FY21, its nine hospitals had recorded average revenue per operating bed of Rs 20,609, and bed occupancy rate of 78 per cent.
Most of the brokerages recommend investors subscribe to the issue for a long-term considering healthy industry growth prospects and the company's strong track record.
The public issue of KIMS had seen a decent response with the issue oversubscribed 3.86 times as the offer received bids for 55.6 million equity shares against IPO size of 14.4 million equity shares. The qualified institutional buyers have put in bids for 5.26 times of their reserved portion while the non-institutional investors portion was subscribed 1.89 times. A part set aside for retail investors has been subscribed 2.90 times. The proceeds from the fresh issue will be used to repay debt of the company and its subsidiaries.
Religare Broking believes that the high-quality healthcare and the company's encouraging financial performance make KIMS well-positioned to consolidate India’s large, unorganized and yet rapidly growing and underserved affordable healthcare market. Besides, KIMS has diversified revenue streams with no single specialty accounting for more than 25 per cent of its total income in the last three years.
At 10:06 am, the stock was trading at Rs 1,003, after hitting a low of Rs 990 on the NSE and BSE. A combined 4.38 million shares have changed hands on the counter on both the exchanges, so far.
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It operates nine multi-specialty hospitals under the 'KIMS Hospitals' brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021.
The company has a flagship hospital at Secunderabad, which, according to Crisil, is one of the largest private hospitals in India at a single location with a capacity of 1,000 beds. At the end of FY21, its nine hospitals had recorded average revenue per operating bed of Rs 20,609, and bed occupancy rate of 78 per cent.
Most of the brokerages recommend investors subscribe to the issue for a long-term considering healthy industry growth prospects and the company's strong track record.
The public issue of KIMS had seen a decent response with the issue oversubscribed 3.86 times as the offer received bids for 55.6 million equity shares against IPO size of 14.4 million equity shares. The qualified institutional buyers have put in bids for 5.26 times of their reserved portion while the non-institutional investors portion was subscribed 1.89 times. A part set aside for retail investors has been subscribed 2.90 times. The proceeds from the fresh issue will be used to repay debt of the company and its subsidiaries.
Religare Broking believes that the high-quality healthcare and the company's encouraging financial performance make KIMS well-positioned to consolidate India’s large, unorganized and yet rapidly growing and underserved affordable healthcare market. Besides, KIMS has diversified revenue streams with no single specialty accounting for more than 25 per cent of its total income in the last three years.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%